Prescription drug · NDA
Egaten (Triclabendazole) NDC 0078-0937
Triclabendazole 250 mg/1 · Tablet · Oral · Novartis Pharmaceuticals Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0078-0937-91 | 00078093791 | 4 TABLET in 1 BLISTER PACK (0078-0937-91)Marketed from Feb 13, 2019 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Egaten
- Generic name (nonproprietary)
- triclabendazole
- Active ingredients
- Triclabendazole — 250 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Novartis Pharmaceuticals CorporationNDC labeler code 0078
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208711
- Marketing start
- Listing expires
- Other FDA classes
- Anthelmintics (Chemical structure)Cytochrome P450 1A2 Inhibitors (Mechanism)Cytochrome P450 2A6 Inhibitors (Mechanism)Cytochrome P450 2B6 Inhibitors (Mechanism)Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 2C9 Inhibitors (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)
- Identifiers
- Product ID 0078-0937_09bbe9c5-f4a7-4140-8a74-809125cd7861SPL ID 09bbe9c5-f4a7-4140-8a74-809125cd7861SPL set ID 5552884e-10ea-450c-9658-d3d4f33c946eRxCUI 2118606, 2118612UNII 4784C8E03O
- Pharmacologic class
- Anthelmintic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400078093791followed by a unit qualifier and the quantityPackage 00078-0937-91. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
EGATEN ® is indicated for the treatment of fascioliasis in patients 6 years of age and older. EGATEN ® tablet is an anthelmintic indicated for the treatment of fascioliasis in patients 6 years of age and older.
Excerpt only. Read the full label for complete information.
About NDC 0078-0937
- What is NDC 0078-0937?
- 0078-0937 is the product NDC for Egaten (triclabendazole), Triclabendazole 250 mg/1 tablet, listed with the FDA by Novartis Pharmaceuticals Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Egaten (Triclabendazole).
- What is the active ingredient?
- Triclabendazole.
- Who is the labeler?
- Novartis Pharmaceuticals Corporation, NDC labeler code 0078. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Egaten?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.